Upgrade to SI Premium - Free Trial

Morgan Stanley on Eli Lilly (LLY): 'We see ~7% upside to '26 M+Z ests'

June 5, 2026 7:38 AM
Morgan Stanley analyst Terence Flynn reiterated an Overweight rating and $1,344.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles